Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Kenya
Kenya: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 87.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Kenya, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Kenya is 87.0%, measured in 2025.
Compared with earlier readings it is down 2.2% on the previous year and up 8.8% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Kenya peaked at 94.0% in 2021 and was at its lowest, 0.0%, in 2008.
That places Kenya 86th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 75.1% | 0.0% | 93.0% | 10 |
| 2020s | 91.0% | 87.0% | 94.0% | 6 |
Countries ranked near Kenya
- 86 Kiribati 87.0% compare
- 86 Dominican Republic 87.0% compare
- 86 Netherlands 87.0% compare
- 86 Niger 87.0% compare
- 86 Lithuania 87.0% compare
More health data for Kenya
- Heat deaths vs projected death rates 1,119 (2090)
- Un projection of annual infant deaths 16,059 (2100)
- Deaths in armed conflicts by region 3 (2026)
- Deaths in armed conflicts by country 3 (2026)
- Age population, age 08, male, interpolated 686,178 (2025)
- Population, male 49.7% (2025)
- Age population, age 06, female, interpolated 680,935 (2025)
- Age population, age 06, male, interpolated 690,593 (2025)
- Age population, age 07, female, interpolated 679,769 (2025)
- Population ages 15-64, female 17.60 million (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Kenya?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Kenya was 87.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Kenya?
- The highest recorded value was 94.0% in 2021.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Kenya?
- The lowest recorded value was 0.0% in 2008.
- How does Kenya rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Kenya ranks 86th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Kenya?
- Over the last ten years it is up 8.8%. The long-run trend across the full record is rising.
- Where does this Kenya data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).